Nils Aage Brünner
Chief Executive Officer at Timpco ApS
Profile
Nils Aage Brünner was the founder of Oncology Venture Sweden AB, founded in 2012, where he held the title of Chief Scientific Officer.
He was also the founder of Scandion Oncology A, founded in 2017, where he held the title of Chief Scientific Officer from 2020 to 2021.
Dr. Brünner's current job(s) include being the Chief Executive Officer at Timpco ApS, Director at 2cureX ApS since 2020, Director at Danish National Research Foundation, Director at CytoTrack ApS, Director at Sino Danish Breast Cancer Research Centre, Director at Gibson Oncology LLC, Director at Genetelligence, Professor at the University of Copenhagen since 2002, and Head-Translational Cancer Research Unit at Danish Cancer Society since 2013.
Dr. Brünner's former job(s) include being the Chief Executive Officer at Timpco HJN ApS, Director at LiPlasome Pharma A, Director at European Organisation for Research & Treatment of Cancer from 2003 to 2006, Independent Director at 2cureX AB, Independent Director at Scandion Oncology A, Assistant Professor at National Cancer Institute, and Chief Executive & Marketing Officer at Wntresearch AB.
Dr. Brünner obtained a doctorate degree from the University of Copenhagen in 1988.
Nils Aage Brünner active positions
Companies | Position | Start |
---|---|---|
University of Copenhagen | Corporate Officer/Principal | 2009-09-14 |
Sino Danish Breast Cancer Research Centre | Director/Board Member | - |
Danish National Research Foundation | Corporate Officer/Principal | - |
Danish Cancer Society
Danish Cancer Society Miscellaneous Commercial ServicesCommercial Services The Danish Cancer Society provides support and resources for those affected by cancer, including patients and their families. The non-profit company is based in Copenhagen, Denmark and has subsidiaries in Denmark. The Danish company offers the latest information on patient involvement in cancer treatment and tools for utilizing patient-reported information. The organization also promotes cancer prevention through screening and works towards reducing the number of cancer cases and improving the quality of life for those who have survived cancer. | Corporate Officer/Principal | 2012-12-31 |
Timpco ApS | Chief Executive Officer | - |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Director/Board Member | 2019-12-31 |
Gibson Oncology LLC
Gibson Oncology LLC BiotechnologyHealth Technology Gibson Oncology LLC composes proven academic researchers and bio tech entrepreneurs. The firm also develops novel oncology drugs to treat resistant cancers with a focus on children. The company was founded by Mark C. Rogers, Theodore C, Solomon, Cliff T. Solomon and Elizabeth L. Rogers and is headquartered in Miami, FL. | Director/Board Member | - |
CytoTrack ApS
CytoTrack ApS Electronic Equipment/InstrumentsElectronic Technology CytoTrack ApS engages in the provision of medical scanners for rare cell detection systems. Its products include CytoTrack CT11 scanner, CytoDisk and CytoCover, and CytoTrack reagent kit. The company was founded by Christian Caspersen, Tom Hede Markussen and Lars Ulrik Nielsen in 2004 and is headquartered in Lyngby, Denmark. | Director/Board Member | - |
Genetelligence | Director/Board Member | - |
Former positions of Nils Aage Brünner
Companies | Position | End |
---|---|---|
░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░ ░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of Nils Aage Brünner
University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
WNTRESEARCH AB | Health Technology |
2CUREX AB | Health Technology |
SCANDION ONCOLOGY A/S | Health Technology |
Private companies | 13 |
---|---|
LiPlasome Pharma A/S
LiPlasome Pharma A/S Pharmaceuticals: MajorHealth Technology LiPlasome Pharma A/S develops, produces and supplies drugs for chemotherapy treatment. It has developed a technology based on incapsulation of chemotherapy in liposomes (fatty molecules) that will only dissolve in and around cancer tissue (tumors or metastases). The firm’s technology will improve chemotherapy treatment within a wide range of cancer diseases significantly as it improves the balance between effect and side effects. LiPlasome’s first drug candicate LiplaCis which is a liposonal formulation of Cisplatin, is in clinical phase 1. The company was founded in January 2001 by Ole Gunner Mouritsen and is headquartered in Hoersholm, Denmark. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
Danish National Research Foundation | |
CytoTrack ApS
CytoTrack ApS Electronic Equipment/InstrumentsElectronic Technology CytoTrack ApS engages in the provision of medical scanners for rare cell detection systems. Its products include CytoTrack CT11 scanner, CytoDisk and CytoCover, and CytoTrack reagent kit. The company was founded by Christian Caspersen, Tom Hede Markussen and Lars Ulrik Nielsen in 2004 and is headquartered in Lyngby, Denmark. | Electronic Technology |
Timpco ApS | |
European Organisation for Research & Treatment of Cancer | |
Danish Cancer Society
Danish Cancer Society Miscellaneous Commercial ServicesCommercial Services The Danish Cancer Society provides support and resources for those affected by cancer, including patients and their families. The non-profit company is based in Copenhagen, Denmark and has subsidiaries in Denmark. The Danish company offers the latest information on patient involvement in cancer treatment and tools for utilizing patient-reported information. The organization also promotes cancer prevention through screening and works towards reducing the number of cancer cases and improving the quality of life for those who have survived cancer. | Commercial Services |
Sino Danish Breast Cancer Research Centre | |
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Health Technology |
Timpco HJN ApS | |
Gibson Oncology LLC
Gibson Oncology LLC BiotechnologyHealth Technology Gibson Oncology LLC composes proven academic researchers and bio tech entrepreneurs. The firm also develops novel oncology drugs to treat resistant cancers with a focus on children. The company was founded by Mark C. Rogers, Theodore C, Solomon, Cliff T. Solomon and Elizabeth L. Rogers and is headquartered in Miami, FL. | Health Technology |
Genetelligence |
- Stock Market
- Insiders
- Nils Aage Brünner